StockSelector.com
  Research, Select, & Monitor Friday, March 22, 2019 6:06:26 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cymabay Therapeutics, Inc.$11.93($.99)(7.66%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cymabay Therapeutics, Inc. has an overall rank of 4337 out of 6607 stocks based on 5 positive rankings and 6 negative rankings.

Positive Rankings
Debt-to-Equity
Cymabay Therapeutics rank is 109
Beat Whisper
According to EarningsWhispers.com, Cymabay Therapeutics beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Low Put/Call
Cymabay Therapeutics has a low Put/Call ratio of 0.20 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cymabay Therapeutics is ranked 529.
90 Day Gain
Cymabay Therapeutics rank is 1056
Up EPS Surprise
Cymabay Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Cymabay Therapeutics is ranked 251.
Negative ROA
Cymabay Therapeutics rank is 336
Negative ROE
Cymabay Therapeutics rank is 403
Price-to-Book
Cymabay Therapeutics rank is 854
10 Day Loss
Cymabay Therapeutics rank is 914
High vPut/Call
Cymabay Therapeutics has a high Put/Call ratio of 0.62 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cymabay Therapeutics is ranked 1756.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.